The European Union's drug regulator, the European Medicines Agency (EMA), has approved the use of another Covid vaccine for adults, APA reports citing BBC.
Made by Novavax, it contains small protein fragments that can teach the body how to fight the pandemic virus. It was designed around the original version of Covid, rather than the new Omicron variant.
Data from two large studies showed the vaccine has an efficacy of around 90%, the EMA said. The EU has already signed a deal to buy up to 200 million doses of the two-shot vaccine. The UK and US are still considering whether to licence its use.
Follow us on Telegram
t.me/apanewsaz
Follow us on Instagram
Follow us on Facebook
Follow us on Twitter
